Your browser doesn't support javascript.
loading
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Viprey, V F; Granata, G; Vendrik, K E W; Davis, G L; Petrosillo, N; Kuijper, E J; Vilken, T; Lammens, C; Schotsman, J J; Benson, A D; Cataldo, M A; van der Kooi, T I I; Wilcox, M H; Davies, K A.
Affiliation
  • Viprey VF; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK. Electronic address: v.f.viprey@leeds.ac.uk.
  • Granata G; National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy.
  • Vendrik KEW; Leiden University Medical Center, Leiden, the Netherlands; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Davis GL; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Petrosillo N; National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy.
  • Kuijper EJ; Leiden University Medical Center, Leiden, the Netherlands; National Institute for Public Health and the Environment, Bilthoven, the Netherlands; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides Difficile (ESGCD).
  • Vilken T; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.
  • Lammens C; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.
  • Schotsman JJ; University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Benson AD; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Cataldo MA; National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy.
  • van der Kooi TII; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Wilcox MH; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides Difficile (ESGCD); Department of Microbiology, Leeds Teaching Hospitals NHS
  • Davies KA; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides Difficile (ESGCD); Department of Microbiology, Leeds Teaching Hospitals NHS
J Hosp Infect ; 131: 213-220, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36462673

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections Type of study: Guideline / Qualitative_research / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Hosp Infect Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections Type of study: Guideline / Qualitative_research / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Hosp Infect Year: 2023 Document type: Article